Busy. Please wait.
Log in with Clever
or

show password
Forgot Password?

Don't have an account?  Sign up 
Sign up using Clever
or

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Idiopathic Generalized Epilepsy Syndromes

Quiz yourself by thinking what should be in each of the black spaces below before clicking on it to display the answer.
        Help!  

Question
Answer
Benign neonatal Convulsions age of onset   Day 1 to 7, peak day 5 of life  
🗑
Clinical features of Benign neonatal convulsions   PArtial clonic, may migrate, apnea, rare tonic, many progress to status epilepticus  
🗑
EEG features of benign neonatal convulsions   Normal, excessively discontinous, focal or multifocal discharges  
🗑
Genetics of benign neonatal convulsions   Idiopathic  
🗑
Treatment of benign neonatal convulsions   Phenobarbital, Fosphenytoin, Benzodiazepins  
🗑
Prognosis of Benign neonatal convulsions   Excellent, rare recurrence of seizures  
🗑
Age of onset of BFNC   Majority durng neonatal period, typically during first week of life  
🗑
EEG features of BFNC   May be normal or show transiet changes, including focal epileptiform discharges  
🗑
Clinical features of BFNC   Tonic-clonic, apnea, autonomic phenomena, normal behavior interictally  
🗑
Genetics of BFNC   Autosomal dominant, 85% penetrance  
🗑
BFNC1 is due to mutation in...   KCNQ2, 20q13.3  
🗑
BFNC2 is due to mutation in...   KCNQ3, 8q24  
🗑
Treatment of BFNC   Resolves spontaneously  
🗑
Prognosis of BFNC   Seizures usually remit by midinfancy, 10-16% will later develop epilepsy  
🗑
Age at onset of Benign myoclonic epilepsy   4 months to 3 years  
🗑
Clinical features of Benign Myoclonic epilepsy   Myoclonic seizures, Absences, Rare GTC  
🗑
EEG features of Benign Myoclonic epilepsy   Generalized polyspie-and-wave discharges  
🗑
Genetics of Benign Myoclonic epilepsy   Unknown but 31% have a family history  
🗑
Treatment of Benign Myoclonic epilepsy   Valproate  
🗑
Prognosis of Benign Myoclonic Epilepsy   Excellent  
🗑
Age at onset of GEFS+ Generalized epilepsy with febrile seizures plus   Infancy to adolescence  
🗑
Clinical features of GEFS+   Febrile seizures beyond age 6, and afebrile myoclonic, astatic, tonic-clonic, absence and complex partial seizures  
🗑
EEG features of GEFS+   May be normal or show generalized spike-and-wave or focal discharges  
🗑
Genetics of GEFS+   Autosomal dominant, up to 80% penetrance  
🗑
Genes linked to GEFS+   SCN1B on 19q13, SCN1A on 2q24, GABRG2 on 5q33-q34  
🗑
Age of onset of Myoclonic astatic epilepsy   7m to 8y, peak 2-6y  
🗑
Clinical features of MAE   Myoclonic, Atonic-astatic, Myoclonic-astatic, Absences, tonic  
🗑
EEG features of MAE   Normal at onset, later slowing of the background and 2-3Hz generalized irregular spike-and-wave discharges  
🗑
Genetics of MAE   Family history of seizures in 32%  
🗑
Treatment of MAE   Valproate, ethosuximide, benzodiazepines... Lamotrigine may be used to treat GCT seizures  
🗑
Drugs that must be avoided in MAE   Carbamazepine and vigabatrin  
🗑
PRognosis of MAE   May be favorable in 50% to 89% although up to 41% may have borderline Iq or mental handicap, and some will develop intractable epilepsy  
🗑
Age at onset of Childhood absence epilepsy CAE   2 to 12 years  
🗑
Clinical features of CAE   More common in girls, Many brief seizures per day. Staring, behavioral arrest without aura or postictal symptoms  
🗑
EEG features of CAE   Normal background with 3Hz generalized spike-and-wave discharges  
🗑
Genetics of CAE   Possibly autosomal dominant, linked to 20q and 8q24.3  
🗑
Treatment of CAE   Ethosuximide, Valproate, Lamotrigine  
🗑
Prognosis of CAE   Patients typically have remission 2 to 6 years after  
🗑
Age at onset of Eyelid myoclonia with and without absences   2 to 14y, peak 6 to 8 years  
🗑
Clinical features of Eyelid myoclonia with and without absences   Myoclonia of eyelids, upward deviation of eyes, and retropulsion fo the head with or without impairment of conciousness, mainly after eye closure. GTC  
🗑
EEG features of eyelid myoclonia with and without absences   Frequent high-amplitude 3-6Hz generaliad spike and polyspike-and-wave discharges, typically seen with eye closure  
🗑
Genetics of Eyelid myoclonia with and without absences   Unknown, but most have a family history of epilepsy  
🗑
Treatment of Eyelid myoclonia with and without absences   Valproate, ethosuximide, clonazepam, possibly levetiracetam  
🗑
Prognosis of Eyelid myoclonia with and without absences   Resistant to treatment and the syndrome is lifelong, even in those with well-controlled seizures  
🗑
Age at onset of Perioral myoclonia with absences   2-13 years, median 10 years  
🗑
Clinical features of Perioral myoclonia with absences   Absence with ictal perioral myoclonia, GTC seizures, Frequent absence status epilepticus  
🗑
EEG features of Perioral myoclonia with absences   Bursts of 4-7Hz generalized, but often asymmetric, spike and polyspike-and-wave, may have focal discharges, ictal EEG 3-4Hz irregular generalized spike and polyspike-and wave discharges  
🗑
Genetics of Perioral myoclonia with absences   Unknown, but 50% have a first-degree relative with idiopathic generalized epilepsy and absences  
🗑
Treatment of Perioral myoclonia with absences   Valrpoate alone or with ethosuximide, lamotrigine, clonazepam; absence status epilepticus should be trated with benzodiazepines  
🗑
Prognosis of Perioral myoclonia with absences   Usually resistant to medication and may be lifelong  
🗑
Age at onset of Epilepsy with myoclonic absences   11m to 12y6m, mean 7y  
🗑
Clinical features of Epilepsy with myoclonic absences   Myoclonic absence seizures. GTC seizures. Absence. Seizures with fall. Absence status  
🗑
EEG features of Epilepsy with myoclonic absences   Generalized 3Hz with a strict correlation between EEG discharge and myoclonia  
🗑
Genetics of Epilepsy with myoclonic absences   20% have a family history of epilepsy  
🗑
Treatment of Epilepsy with myoclonic absences   Valproate with ethosuximide, Benzodiazepines, Lamotrigine  
🗑
PRognosis of Epilepsy witn myoclonic absences   epilepsy improves in approx. 1/3 Presence of GTC seizures is a poor prognosis  
🗑
Age at onset of Juvenile myoclonic epilepsy, JME   Late childhood to late adolescence  
🗑
Clinical features of JME   Absence seizures in childhood. Myoclonus early adolescence. GTC adolescence  
🗑
EEG features of JME   Normal background with 3-4HZ generalized atypical spike-and-wave discharges  
🗑
Genetics JME   Complex inheritance linked to 6p, 18, 15q14, and 8q23.3-q24.1  
🗑
Treatment of JME   Valproate, Lamotrigine, Levetiracetam  
🗑
Prognosis of JME   Response to AED is usually good, but lifelong treatment is frequently required  
🗑
Age at onset of Juvenile absence epilepsy JAE   Adolescence  
🗑
Clinical features of JAE   Daily brief absence seizures, fewer than childhood absence epilepsy, GTC seizures  
🗑
EEG features of JAE   Normal bacground with 3-4Hz generalized spike-and-wave discharges  
🗑
Genetics of JAE   Possible localization to 21q22.1  
🗑
Treatment of JAE   Valproate, Lamotrigine, Ethosuximide  
🗑
Prognosis of JAE   Response to AED is usually good but lifelong treatment is frequently required  
🗑
Age at onset of Epilepsy with grand mal on awakening   6-35 years  
🗑
Clinical features of Epilepsy w/GM on awakening   Seizures occur shortly after waking up, may be associated with absence or myoclonic seizures  
🗑
EEG features of Epilepsy w/GM on awakening   Slow background, generalized spike-and-wave discharges, photosensitivity  
🗑
Genetics of Epilepsy w/GM on awakening   Thought to be genetic; 3.3% have a first-degree relative w/epilepsy  
🗑
Prognosis of Epilepsy w/GM on awakening   Response to AED is good, but relapse occurs with AED discontinuation and sleep deprivation  
🗑
EEG features of Perioral myoclonia with absences   Bursts of 4-7Hz generalized, but often asymmetric, spike and polyspike-and-wave, may have focal discharges, ictal EEG 3-4Hz irregular generalized spike and polyspike-and wave discharges  
🗑
Genetics of Perioral myoclonia with absences   Unknown, but 50% have a first-degree relative with idiopathic generalized epilepsy and absences  
🗑
Treatment of Perioral myoclonia with absences   Valrpoate alone or with ethosuximide, lamotrigine, clonazepam; absence status epilepticus should be trated with benzodiazepines  
🗑
Prognosis of Perioral myoclonia with absences   Usually resistant to medication and may be lifelong  
🗑
Age at onset of Epilepsy with myoclonic absences   11m to 12y6m, mean 7y  
🗑
Clinical features of Epilepsy with myoclonic absences   Myoclonic absence seizures. GTC seizures. Absence. Seizures with fall. Absence status  
🗑
EEG features of Epilepsy with myoclonic absences   Generalized 3Hz with a strict correlation between EEG discharge and myoclonia  
🗑
Genetics of Epilepsy with myoclonic absences   20% have a family history of epilepsy  
🗑
Treatment of Epilepsy with myoclonic absences   Valproate with ethosuximide, Benzodiazepines, Lamotrigine  
🗑
PRognosis of Epilepsy witn myoclonic absences   epilepsy improves in approx. 1/3 Presence of GTC seizures is a poor prognosis  
🗑
Age at onset of Juvenile myoclonic epilepsy, JME   Late childhood to late adolescence  
🗑
Clinical features of JME   Absence seizures in childhood. Myoclonus early adolescence. GTC adolescence  
🗑
EEG features of JME   Normal background with 3-4HZ generalized atypical spike-and-wave discharges  
🗑
Genetics JME   Complex inheritance linked to 6p, 18, 15q14, and 8q23.3-q24.1  
🗑
Treatment of JME   Valproate, Lamotrigine, Levetiracetam  
🗑
Prognosis of JME   Response to AED is usually good, but lifelong treatment is frequently required  
🗑
Age at onset of Juvenile absence epilepsy JAE   Adolescence  
🗑
Clinical features of JAE   Daily brief absence seizures, fewer than childhood absence epilepsy, GTC seizures  
🗑
EEG features of JAE   Normal bacground with 3-4Hz generalized spike-and-wave discharges  
🗑
Genetics of JAE   Possible localization to 21q22.1  
🗑
Treatment of JAE   Valproate, Lamotrigine, Ethosuximide  
🗑
Prognosis of JAE   Response to AED is usually good but lifelong treatment is frequently required  
🗑
Age at onset of Epilepsy with grand mal on awakening   6-35 years  
🗑
Clinical features of Epilepsy w/GM on awakening   Seizures occur shortly after waking up, may be associated with absence or myoclonic seizures  
🗑
EEG features of Epilepsy w/GM on awakening   Slow background, generalized spike-and-wave discharges, photosensitivity  
🗑
Genetics of Epilepsy w/GM on awakening   Thought to be genetic; 3.3% have a first-degree relative w/epilepsy  
🗑
Prognosis of Epilepsy w/GM on awakening   Response to AED is good, but relapse occurs with AED discontinuation and sleep deprivation  
🗑
   
🗑


   

Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
 
To hide a column, click on the column name.
 
To hide the entire table, click on the "Hide All" button.
 
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
 
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.

 
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how
Created by: 1042022037
Popular Medical sets